
Heska Corporation HSKA
Quarterly report 2023-Q1
added 05-05-2023
Heska Corporation Cash Conversion Cycle 2011-2025 | HSKA
Annual Cash Conversion Cycle Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 138 | 115 | 113 | 164 | 147 | 169 | 122 | 109 | 104 | 114 | 118 | 116 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 | 104 | 127 |
Quarterly Cash Conversion Cycle Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 165 | - | 154 | 144 | 137 | - | 118 | 102 | 110 | - | 119 | 144 | 188 | 41 | 148 | 165 | 150 | 44.1 | 148 | 148 | 140 | 39.3 | 173 | 157 | 160 | 48.1 | 118 | 133 | 125 | 24.8 | 47.9 | 57.8 | 58.8 | 0.91 | 53.5 | 52 | 55.6 | 0.81 | 65.9 | 50.9 | 59.8 | 0.77 | 65.2 | 64.9 | 70.2 | 1.02 | 72 | 77.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 188 | 0.77 | 93.3 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 16.38 | 3.97 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.6 | -1.23 % | $ 2.03 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 39.39 | 1.97 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
83.5 | $ 228.73 | 0.98 % | $ 167 B | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 11.97 | 0.67 % | $ 340 M | ||
|
DexCom
DXCM
|
133 | $ 67.19 | 0.34 % | $ 25.9 B | ||
|
Exact Sciences Corporation
EXAS
|
130 | $ 101.46 | -0.04 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 27.23 | 0.31 % | $ 823 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.72 | 0.78 % | $ 1.11 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.41 | -4.75 % | $ 109 K | ||
|
Co-Diagnostics
CODX
|
299 | $ 0.33 | -3.34 % | $ 9.68 M | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 28.72 | -0.28 % | $ 1.21 B | ||
|
Guardant Health
GH
|
49.1 | $ 103.82 | 1.72 % | $ 12.7 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 223.38 | 0.52 % | $ 40.5 B | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
142 | $ 135.16 | 0.22 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 197.73 | 2.46 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 184.0 | 0.82 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.85 | - | $ 1.02 B | ||
|
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 264.75 | 0.22 % | $ 22.2 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 187.27 | 0.37 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
108 | $ 707.12 | 0.41 % | $ 58.3 B | ||
|
Lantheus Holdings
LNTH
|
90.9 | $ 66.85 | 0.35 % | $ 4.63 B | ||
|
Agilent Technologies
A
|
111 | $ 140.96 | 0.93 % | $ 42.9 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 405.6 | 0.84 % | $ 29.8 B | ||
|
Myriad Genetics
MYGN
|
45.1 | $ 7.22 | 0.14 % | $ 654 M | ||
|
Biomerica
BMRA
|
172 | $ 2.53 | -1.94 % | $ 5.81 M | ||
|
Bioventus
BVS
|
208 | $ 7.64 | 1.13 % | $ 479 M | ||
|
NeoGenomics
NEO
|
82.3 | $ 11.87 | 0.16 % | $ 1.5 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 6.82 | -0.66 % | $ 1.48 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |